0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Rifaximin API Market Research Report 2020
Published Date: September 2020
|
Report Code: QYRE-Auto-27G3178
Home | Category |Health |Pharmacy
Global Rifaximin API Market Research Report 2020

Global Rifaximin API Market Research Report 2020

Code: QYRE-Auto-27G3178
Report
September 2020
92 Pages
QYResearch
Region: Global, North America, France, Germany, Europe, Canada, Malaysia, Philippines, Taiwan, Australia, India, Thailand, South Korea, Japan, Italy, Vietnam, Indonesia, Saudi Arabia, Turkey, Brazil, Argentina, Middle East & Africa,
Description
Table of Content
Tables & Figures
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Rifaximin API market is segmented into
    99% Purity
    >99% Purity
Segment by Application
    Pharmaceuticals
    Others
Global Rifaximin API Market: Regional Analysis
The Rifaximin API market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Rifaximin API market report are:
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
Global Rifaximin API Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Rifaximin API market include:
    Salix Pharmaceuticals
    Lupin
    LGM Pharma
    B Joshi Agrochem Pharma
    Triveni Interchem
1 Rifaximin API Market Overview
1.1 Product Overview and Scope of Rifaximin API
1.2 Rifaximin API Segment by Type
1.2.1 Global Rifaximin API Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 99% Purity
1.2.3 >99% Purity
1.3 Rifaximin API Segment by Application
1.3.1 Rifaximin API Sales Comparison by Application: 2020 VS 2026
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Rifaximin API Market Size Estimates and Forecasts
1.4.1 Global Rifaximin API Revenue 2015-2026
1.4.2 Global Rifaximin API Sales 2015-2026
1.4.3 Rifaximin API Market Size by Region: 2020 Versus 2026
1.5 Rifaximin API Industry
1.6 Rifaximin API Market Trends
2 Global Rifaximin API Market Competition by Manufacturers
2.1 Global Rifaximin API Sales Market Share by Manufacturers (2015-2020)
2.2 Global Rifaximin API Revenue Share by Manufacturers (2015-2020)
2.3 Global Rifaximin API Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Rifaximin API Manufacturing Sites, Area Served, Product Type
2.5 Rifaximin API Market Competitive Situation and Trends
2.5.1 Rifaximin API Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Rifaximin API Players (Opinion Leaders)
3 Rifaximin API Retrospective Market Scenario by Region
3.1 Global Rifaximin API Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Rifaximin API Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Rifaximin API Market Facts & Figures by Country
3.3.1 North America Rifaximin API Sales by Country
3.3.2 North America Rifaximin API Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rifaximin API Market Facts & Figures by Country
3.4.1 Europe Rifaximin API Sales by Country
3.4.2 Europe Rifaximin API Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rifaximin API Market Facts & Figures by Region
3.5.1 Asia Pacific Rifaximin API Sales by Region
3.5.2 Asia Pacific Rifaximin API Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Rifaximin API Market Facts & Figures by Country
3.6.1 Latin America Rifaximin API Sales by Country
3.6.2 Latin America Rifaximin API Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Rifaximin API Market Facts & Figures by Country
3.7.1 Middle East and Africa Rifaximin API Sales by Country
3.7.2 Middle East and Africa Rifaximin API Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Rifaximin API Historic Market Analysis by Type
4.1 Global Rifaximin API Sales Market Share by Type (2015-2020)
4.2 Global Rifaximin API Revenue Market Share by Type (2015-2020)
4.3 Global Rifaximin API Price Market Share by Type (2015-2020)
4.4 Global Rifaximin API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Rifaximin API Historic Market Analysis by Application
5.1 Global Rifaximin API Sales Market Share by Application (2015-2020)
5.2 Global Rifaximin API Revenue Market Share by Application (2015-2020)
5.3 Global Rifaximin API Price by Application (2015-2020)
6 Company Profiles and Key Figures in Rifaximin API Business
6.1 Salix Pharmaceuticals
6.1.1 Corporation Information
6.1.2 Salix Pharmaceuticals Description, Business Overview and Total Revenue
6.1.3 Salix Pharmaceuticals Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Salix Pharmaceuticals Products Offered
6.1.5 Salix Pharmaceuticals Recent Development
6.2 Lupin
6.2.1 Lupin Corporation Information
6.2.2 Lupin Description, Business Overview and Total Revenue
6.2.3 Lupin Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Lupin Products Offered
6.2.5 Lupin Recent Development
6.3 LGM Pharma
6.3.1 LGM Pharma Corporation Information
6.3.2 LGM Pharma Description, Business Overview and Total Revenue
6.3.3 LGM Pharma Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.3.4 LGM Pharma Products Offered
6.3.5 LGM Pharma Recent Development
6.4 B Joshi Agrochem Pharma
6.4.1 B Joshi Agrochem Pharma Corporation Information
6.4.2 B Joshi Agrochem Pharma Description, Business Overview and Total Revenue
6.4.3 B Joshi Agrochem Pharma Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.4.4 B Joshi Agrochem Pharma Products Offered
6.4.5 B Joshi Agrochem Pharma Recent Development
6.5 Triveni Interchem
6.5.1 Triveni Interchem Corporation Information
6.5.2 Triveni Interchem Description, Business Overview and Total Revenue
6.5.3 Triveni Interchem Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Triveni Interchem Products Offered
6.5.5 Triveni Interchem Recent Development
7 Rifaximin API Manufacturing Cost Analysis
7.1 Rifaximin API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rifaximin API
7.4 Rifaximin API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rifaximin API Distributors List
8.3 Rifaximin API Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Rifaximin API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rifaximin API by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Rifaximin API by Type (2021-2026)
10.2 Rifaximin API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rifaximin API by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Rifaximin API by Application (2021-2026)
10.3 Rifaximin API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rifaximin API by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Rifaximin API by Region (2021-2026)
10.4 North America Rifaximin API Estimates and Projections (2021-2026)
10.5 Europe Rifaximin API Estimates and Projections (2021-2026)
10.6 Asia Pacific Rifaximin API Estimates and Projections (2021-2026)
10.7 Latin America Rifaximin API Estimates and Projections (2021-2026)
10.8 Middle East and Africa Rifaximin API Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Rifaximin API Sales (Kiloton) Growth Rate Comparison by Type (2015-2026)
    Table 2. Global Rifaximin API Sales (Kiloton) Comparison by Application: 2020 VS 2026
    Table 3. Global Rifaximin API Market Size by Type (Kiloton) (US$ Million) (2020 VS 2026)
    Table 4. Global Key Rifaximin API Manufacturers Covered in This Study
    Table 5. Global Rifaximin API Sales (Kiloton) by Manufacturers (2015-2020)
    Table 6. Global Rifaximin API Sales Share by Manufacturers (2015-2020)
    Table 7. Global Rifaximin API Revenue (Million USD) by Manufacturers (2015-2020)
    Table 8. Global Rifaximin API Revenue Share by Manufacturers (2015-2020)
    Table 9. Global Market Rifaximin API Average Price (US$/Ton) of Key Manufacturers (2015-2020)
    Table 10. Manufacturers Rifaximin API Sales Sites and Area Served
    Table 11. Manufacturers Rifaximin API Product Types
    Table 12. Global Rifaximin API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Rifaximin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rifaximin API as of 2019)
    Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Main Points Interviewed from Key Rifaximin API Players
    Table 16. Global Rifaximin API Sales (Kiloton) by Region (2015-2020)
    Table 17. Global Rifaximin API Sales Market Share by Region (2015-2020)
    Table 18. Global Rifaximin API Revenue (Million US$) by Region (2015-2020)
    Table 19. Global Rifaximin API Revenue Market Share by Region (2015-2020)
    Table 20. North America Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 21. North America Rifaximin API Sales Market Share by Country (2015-2020)
    Table 22. North America Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 23. North America Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 24. Europe Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 25. Europe Rifaximin API Sales Market Share by Country (2015-2020)
    Table 26. Europe Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 27. Europe Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 28. Asia Pacific Rifaximin API Sales by Region (2015-2020) (Kiloton)
    Table 29. Asia Pacific Rifaximin API Sales Market Share by Region (2015-2020)
    Table 30. Asia Pacific Rifaximin API Revenue by Region (2015-2020) (US$ Million)
    Table 31. Asia Pacific Rifaximin API Revenue Market Share by Region (2015-2020)
    Table 32. Latin America Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 33. Latin America Rifaximin API Sales Market Share by Country (2015-2020)
    Table 34. Latin America Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 35. Latin America Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 36. Middle East and Africa Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 37. Middle East and Africa Rifaximin API Sales Market Share by Country (2015-2020)
    Table 38. Middle East and Africa Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 39. Middle East and Africa Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 40. Global Rifaximin API Sales (Kiloton) by Type (2015-2020)
    Table 41. Global Rifaximin API Sales Share by Type (2015-2020)
    Table 42. Global Rifaximin API Revenue (Million US$) by Type (2015-2020)
    Table 43. Global Rifaximin API Revenue Share by Type (2015-2020)
    Table 44. Global Rifaximin API Price (US$/Ton) by Type (2015-2020)
    Table 45. Global Rifaximin API Sales (Kiloton) by Application (2015-2020)
    Table 46. Global Rifaximin API Sales Market Share by Application (2015-2020)
    Table 47. Global Rifaximin API Sales Growth Rate by Application (2015-2020)
    Table 48. Salix Pharmaceuticals Rifaximin API Corporation Information
    Table 49. Salix Pharmaceuticals Description and Business Overview
    Table 50. Salix Pharmaceuticals Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 51. Salix Pharmaceuticals Main Product
    Table 52. Salix Pharmaceuticals Recent Development
    Table 53. Lupin Rifaximin API Corporation Information
    Table 54. Lupin Corporation Information
    Table 55. Lupin Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 56. Lupin Main Product
    Table 57. Lupin Recent Development
    Table 58. LGM Pharma Rifaximin API Corporation Information
    Table 59. LGM Pharma Corporation Information
    Table 60. LGM Pharma Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 61. LGM Pharma Main Product
    Table 62. LGM Pharma Recent Development
    Table 63. B Joshi Agrochem Pharma Rifaximin API Corporation Information
    Table 64. B Joshi Agrochem Pharma Corporation Information
    Table 65. B Joshi Agrochem Pharma Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 66. B Joshi Agrochem Pharma Main Product
    Table 67. B Joshi Agrochem Pharma Recent Development
    Table 68. Triveni Interchem Rifaximin API Corporation Information
    Table 69. Triveni Interchem Corporation Information
    Table 70. Triveni Interchem Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 71. Triveni Interchem Main Product
    Table 72. Triveni Interchem Recent Development
    Table 73. Sales Base and Market Concentration Rate of Raw Material
    Table 74. Key Suppliers of Raw Materials
    Table 75. Rifaximin API Distributors List
    Table 76. Rifaximin API Customers List
    Table 77. Market Key Trends
    Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 79. Key Challenges
    Table 80. Global Rifaximin API Sales (Kiloton) Forecast by Type (2021-2026)
    Table 81. Global Rifaximin API Sales Market Share Forecast by Type (2021-2026)
    Table 82. Global Rifaximin API Revenue (Million US$) Forecast by Type (2021-2026)
    Table 83. Global Rifaximin API Revenue (Million US$) Market Share Forecast by Type (2021-2026)
    Table 84. Global Rifaximin API Sales (Kiloton) Forecast by Application (2021-2026)
    Table 85. Global Rifaximin API Revenue (Million US$) Forecast by Application (2021-2026)
    Table 86. Global Rifaximin API Sales (Kiloton) Forecast by Region (2021-2026)
    Table 87. Global Rifaximin API Sales Market Share Forecast by Region (2021-2026)
    Table 88. Global Rifaximin API Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 89. Global Rifaximin API Revenue Market Share Forecast by Region (2021-2026)
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Picture of Rifaximin API
    Figure 2. Global Rifaximin API Sales Market Share by Type: 2020 VS 2026
    Figure 3. 99% Purity Product Picture
    Figure 4. >99% Purity Product Picture
    Figure 5. Global Rifaximin API Consumption Market Share by Application: 2020 VS 2026
    Figure 6. Pharmaceuticals
    Figure 7. Others
    Figure 8. Global Rifaximin API Market Size 2015-2026 (US$ Million)
    Figure 9. Global Rifaximin API Sales Capacity (Kiloton) (2015-2026)
    Figure 10. Global Rifaximin API Market Size Market Share by Region: 2020 Versus 2026
    Figure 11. Rifaximin API Sales Share by Manufacturers in 2020
    Figure 12. Global Rifaximin API Revenue Share by Manufacturers in 2019
    Figure 13. The Global 5 and 10 Largest Players: Market Share by Rifaximin API Revenue in 2019
    Figure 14. Rifaximin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 15. Global Rifaximin API Sales Market Share by Region (2015-2020)
    Figure 16. Global Rifaximin API Sales Market Share by Region in 2019
    Figure 17. Global Rifaximin API Revenue Market Share by Region (2015-2020)
    Figure 18. Global Rifaximin API Revenue Market Share by Region in 2019
    Figure 19. North America Rifaximin API Sales Market Share by Country in 2019
    Figure 20. North America Rifaximin API Revenue Market Share by Country in 2019
    Figure 21. U.S. Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 22. U.S. Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 23. Canada Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 24. Canada Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 25. Europe Rifaximin API Sales Market Share by Country in 2019
    Figure 26. Europe Rifaximin API Revenue Market Share by Country in 2019
    Figure 27. Germany Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 28. Germany Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 29. France Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 30. France Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 31. U.K. Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 32. U.K. Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 33. Italy Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 34. Italy Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 35. Russia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 36. Russia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 37. Asia Pacific Rifaximin API Sales Market Share by Region in 2019
    Figure 38. Asia Pacific Rifaximin API Revenue Market Share by Region in 2019
    Figure 39. China Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 40. China Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 41. Japan Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 42. Japan Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 43. South Korea Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 44. South Korea Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. India Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 46. India Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. Australia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 48. Australia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 49. Taiwan Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 50. Taiwan Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. Indonesia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 52. Indonesia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. Thailand Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 54. Thailand Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. Malaysia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 56. Malaysia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. Philippines Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 58. Philippines Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Vietnam Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 60. Vietnam Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Latin America Rifaximin API Sales Market Share by Country in 2019
    Figure 62. Latin America Rifaximin API Revenue Market Share by Country in 2019
    Figure 63. Mexico Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 64. Mexico Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. Brazil Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 66. Brazil Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. Argentina Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 68. Argentina Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. Middle East and Africa Rifaximin API Sales Market Share by Country in 2019
    Figure 70. Middle East and Africa Rifaximin API Revenue Market Share by Country in 2019
    Figure 71. Turkey Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 72. Turkey Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Saudi Arabia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 74. Saudi Arabia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. U.A.E Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 76. U.A.E Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Sales Market Share of Rifaximin API by Type (2015-2020)
    Figure 78. Sales Market Share of Rifaximin API by Type in 2019
    Figure 79. Revenue Share of Rifaximin API by Type (2015-2020)
    Figure 80. Revenue Market Share of Rifaximin API by Type in 2019
    Figure 81. Global Rifaximin API Sales Growth by Type (2015-2020) (Kiloton)
    Figure 82. Global Rifaximin API Sales Market Share by Application (2015-2020)
    Figure 83. Global Rifaximin API Sales Market Share by Application in 2019
    Figure 84. Global Revenue Share of Rifaximin API by Application (2015-2020)
    Figure 85. Global Revenue Share of Rifaximin API by Application in 2020
    Figure 86. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 87. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 88. LGM Pharma Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 89. B Joshi Agrochem Pharma Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 90. Triveni Interchem Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 91. Price Trend of Key Raw Materials
    Figure 92. Manufacturing Cost Structure of Rifaximin API
    Figure 93. Manufacturing Process Analysis of Rifaximin API
    Figure 94. Rifaximin API Industrial Chain Analysis
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Porter's Five Forces Analysis
    Figure 98. North America Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 99. North America Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 100. Europe Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 101. Europe Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 102. Latin America Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 103. Latin America Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 104. Middle East and Africa Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 105. Middle East and Africa Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 106. Asia Pacific Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 107. Asia Pacific Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Rifaximin API market is segmented into
    99% Purity
    >99% Purity
Segment by Application
    Pharmaceuticals
    Others
Global Rifaximin API Market: Regional Analysis
The Rifaximin API market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Rifaximin API market report are:
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
Global Rifaximin API Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Rifaximin API market include:
    Salix Pharmaceuticals
    Lupin
    LGM Pharma
    B Joshi Agrochem Pharma
    Triveni Interchem
Read More
1 Rifaximin API Market Overview
1.1 Product Overview and Scope of Rifaximin API
1.2 Rifaximin API Segment by Type
1.2.1 Global Rifaximin API Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 99% Purity
1.2.3 >99% Purity
1.3 Rifaximin API Segment by Application
1.3.1 Rifaximin API Sales Comparison by Application: 2020 VS 2026
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Rifaximin API Market Size Estimates and Forecasts
1.4.1 Global Rifaximin API Revenue 2015-2026
1.4.2 Global Rifaximin API Sales 2015-2026
1.4.3 Rifaximin API Market Size by Region: 2020 Versus 2026
1.5 Rifaximin API Industry
1.6 Rifaximin API Market Trends
2 Global Rifaximin API Market Competition by Manufacturers
2.1 Global Rifaximin API Sales Market Share by Manufacturers (2015-2020)
2.2 Global Rifaximin API Revenue Share by Manufacturers (2015-2020)
2.3 Global Rifaximin API Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Rifaximin API Manufacturing Sites, Area Served, Product Type
2.5 Rifaximin API Market Competitive Situation and Trends
2.5.1 Rifaximin API Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Rifaximin API Players (Opinion Leaders)
3 Rifaximin API Retrospective Market Scenario by Region
3.1 Global Rifaximin API Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Rifaximin API Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Rifaximin API Market Facts & Figures by Country
3.3.1 North America Rifaximin API Sales by Country
3.3.2 North America Rifaximin API Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rifaximin API Market Facts & Figures by Country
3.4.1 Europe Rifaximin API Sales by Country
3.4.2 Europe Rifaximin API Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rifaximin API Market Facts & Figures by Region
3.5.1 Asia Pacific Rifaximin API Sales by Region
3.5.2 Asia Pacific Rifaximin API Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Rifaximin API Market Facts & Figures by Country
3.6.1 Latin America Rifaximin API Sales by Country
3.6.2 Latin America Rifaximin API Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Rifaximin API Market Facts & Figures by Country
3.7.1 Middle East and Africa Rifaximin API Sales by Country
3.7.2 Middle East and Africa Rifaximin API Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Rifaximin API Historic Market Analysis by Type
4.1 Global Rifaximin API Sales Market Share by Type (2015-2020)
4.2 Global Rifaximin API Revenue Market Share by Type (2015-2020)
4.3 Global Rifaximin API Price Market Share by Type (2015-2020)
4.4 Global Rifaximin API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Rifaximin API Historic Market Analysis by Application
5.1 Global Rifaximin API Sales Market Share by Application (2015-2020)
5.2 Global Rifaximin API Revenue Market Share by Application (2015-2020)
5.3 Global Rifaximin API Price by Application (2015-2020)
6 Company Profiles and Key Figures in Rifaximin API Business
6.1 Salix Pharmaceuticals
6.1.1 Corporation Information
6.1.2 Salix Pharmaceuticals Description, Business Overview and Total Revenue
6.1.3 Salix Pharmaceuticals Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Salix Pharmaceuticals Products Offered
6.1.5 Salix Pharmaceuticals Recent Development
6.2 Lupin
6.2.1 Lupin Corporation Information
6.2.2 Lupin Description, Business Overview and Total Revenue
6.2.3 Lupin Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Lupin Products Offered
6.2.5 Lupin Recent Development
6.3 LGM Pharma
6.3.1 LGM Pharma Corporation Information
6.3.2 LGM Pharma Description, Business Overview and Total Revenue
6.3.3 LGM Pharma Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.3.4 LGM Pharma Products Offered
6.3.5 LGM Pharma Recent Development
6.4 B Joshi Agrochem Pharma
6.4.1 B Joshi Agrochem Pharma Corporation Information
6.4.2 B Joshi Agrochem Pharma Description, Business Overview and Total Revenue
6.4.3 B Joshi Agrochem Pharma Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.4.4 B Joshi Agrochem Pharma Products Offered
6.4.5 B Joshi Agrochem Pharma Recent Development
6.5 Triveni Interchem
6.5.1 Triveni Interchem Corporation Information
6.5.2 Triveni Interchem Description, Business Overview and Total Revenue
6.5.3 Triveni Interchem Rifaximin API Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Triveni Interchem Products Offered
6.5.5 Triveni Interchem Recent Development
7 Rifaximin API Manufacturing Cost Analysis
7.1 Rifaximin API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rifaximin API
7.4 Rifaximin API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rifaximin API Distributors List
8.3 Rifaximin API Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Rifaximin API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rifaximin API by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Rifaximin API by Type (2021-2026)
10.2 Rifaximin API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rifaximin API by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Rifaximin API by Application (2021-2026)
10.3 Rifaximin API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rifaximin API by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Rifaximin API by Region (2021-2026)
10.4 North America Rifaximin API Estimates and Projections (2021-2026)
10.5 Europe Rifaximin API Estimates and Projections (2021-2026)
10.6 Asia Pacific Rifaximin API Estimates and Projections (2021-2026)
10.7 Latin America Rifaximin API Estimates and Projections (2021-2026)
10.8 Middle East and Africa Rifaximin API Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Read More
List of Tables
    Table 1. Global Rifaximin API Sales (Kiloton) Growth Rate Comparison by Type (2015-2026)
    Table 2. Global Rifaximin API Sales (Kiloton) Comparison by Application: 2020 VS 2026
    Table 3. Global Rifaximin API Market Size by Type (Kiloton) (US$ Million) (2020 VS 2026)
    Table 4. Global Key Rifaximin API Manufacturers Covered in This Study
    Table 5. Global Rifaximin API Sales (Kiloton) by Manufacturers (2015-2020)
    Table 6. Global Rifaximin API Sales Share by Manufacturers (2015-2020)
    Table 7. Global Rifaximin API Revenue (Million USD) by Manufacturers (2015-2020)
    Table 8. Global Rifaximin API Revenue Share by Manufacturers (2015-2020)
    Table 9. Global Market Rifaximin API Average Price (US$/Ton) of Key Manufacturers (2015-2020)
    Table 10. Manufacturers Rifaximin API Sales Sites and Area Served
    Table 11. Manufacturers Rifaximin API Product Types
    Table 12. Global Rifaximin API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Rifaximin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rifaximin API as of 2019)
    Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Main Points Interviewed from Key Rifaximin API Players
    Table 16. Global Rifaximin API Sales (Kiloton) by Region (2015-2020)
    Table 17. Global Rifaximin API Sales Market Share by Region (2015-2020)
    Table 18. Global Rifaximin API Revenue (Million US$) by Region (2015-2020)
    Table 19. Global Rifaximin API Revenue Market Share by Region (2015-2020)
    Table 20. North America Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 21. North America Rifaximin API Sales Market Share by Country (2015-2020)
    Table 22. North America Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 23. North America Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 24. Europe Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 25. Europe Rifaximin API Sales Market Share by Country (2015-2020)
    Table 26. Europe Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 27. Europe Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 28. Asia Pacific Rifaximin API Sales by Region (2015-2020) (Kiloton)
    Table 29. Asia Pacific Rifaximin API Sales Market Share by Region (2015-2020)
    Table 30. Asia Pacific Rifaximin API Revenue by Region (2015-2020) (US$ Million)
    Table 31. Asia Pacific Rifaximin API Revenue Market Share by Region (2015-2020)
    Table 32. Latin America Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 33. Latin America Rifaximin API Sales Market Share by Country (2015-2020)
    Table 34. Latin America Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 35. Latin America Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 36. Middle East and Africa Rifaximin API Sales by Country (2015-2020) (Kiloton)
    Table 37. Middle East and Africa Rifaximin API Sales Market Share by Country (2015-2020)
    Table 38. Middle East and Africa Rifaximin API Revenue by Country (2015-2020) (US$ Million)
    Table 39. Middle East and Africa Rifaximin API Revenue Market Share by Country (2015-2020)
    Table 40. Global Rifaximin API Sales (Kiloton) by Type (2015-2020)
    Table 41. Global Rifaximin API Sales Share by Type (2015-2020)
    Table 42. Global Rifaximin API Revenue (Million US$) by Type (2015-2020)
    Table 43. Global Rifaximin API Revenue Share by Type (2015-2020)
    Table 44. Global Rifaximin API Price (US$/Ton) by Type (2015-2020)
    Table 45. Global Rifaximin API Sales (Kiloton) by Application (2015-2020)
    Table 46. Global Rifaximin API Sales Market Share by Application (2015-2020)
    Table 47. Global Rifaximin API Sales Growth Rate by Application (2015-2020)
    Table 48. Salix Pharmaceuticals Rifaximin API Corporation Information
    Table 49. Salix Pharmaceuticals Description and Business Overview
    Table 50. Salix Pharmaceuticals Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 51. Salix Pharmaceuticals Main Product
    Table 52. Salix Pharmaceuticals Recent Development
    Table 53. Lupin Rifaximin API Corporation Information
    Table 54. Lupin Corporation Information
    Table 55. Lupin Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 56. Lupin Main Product
    Table 57. Lupin Recent Development
    Table 58. LGM Pharma Rifaximin API Corporation Information
    Table 59. LGM Pharma Corporation Information
    Table 60. LGM Pharma Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 61. LGM Pharma Main Product
    Table 62. LGM Pharma Recent Development
    Table 63. B Joshi Agrochem Pharma Rifaximin API Corporation Information
    Table 64. B Joshi Agrochem Pharma Corporation Information
    Table 65. B Joshi Agrochem Pharma Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 66. B Joshi Agrochem Pharma Main Product
    Table 67. B Joshi Agrochem Pharma Recent Development
    Table 68. Triveni Interchem Rifaximin API Corporation Information
    Table 69. Triveni Interchem Corporation Information
    Table 70. Triveni Interchem Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
    Table 71. Triveni Interchem Main Product
    Table 72. Triveni Interchem Recent Development
    Table 73. Sales Base and Market Concentration Rate of Raw Material
    Table 74. Key Suppliers of Raw Materials
    Table 75. Rifaximin API Distributors List
    Table 76. Rifaximin API Customers List
    Table 77. Market Key Trends
    Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 79. Key Challenges
    Table 80. Global Rifaximin API Sales (Kiloton) Forecast by Type (2021-2026)
    Table 81. Global Rifaximin API Sales Market Share Forecast by Type (2021-2026)
    Table 82. Global Rifaximin API Revenue (Million US$) Forecast by Type (2021-2026)
    Table 83. Global Rifaximin API Revenue (Million US$) Market Share Forecast by Type (2021-2026)
    Table 84. Global Rifaximin API Sales (Kiloton) Forecast by Application (2021-2026)
    Table 85. Global Rifaximin API Revenue (Million US$) Forecast by Application (2021-2026)
    Table 86. Global Rifaximin API Sales (Kiloton) Forecast by Region (2021-2026)
    Table 87. Global Rifaximin API Sales Market Share Forecast by Region (2021-2026)
    Table 88. Global Rifaximin API Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 89. Global Rifaximin API Revenue Market Share Forecast by Region (2021-2026)
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Picture of Rifaximin API
    Figure 2. Global Rifaximin API Sales Market Share by Type: 2020 VS 2026
    Figure 3. 99% Purity Product Picture
    Figure 4. >99% Purity Product Picture
    Figure 5. Global Rifaximin API Consumption Market Share by Application: 2020 VS 2026
    Figure 6. Pharmaceuticals
    Figure 7. Others
    Figure 8. Global Rifaximin API Market Size 2015-2026 (US$ Million)
    Figure 9. Global Rifaximin API Sales Capacity (Kiloton) (2015-2026)
    Figure 10. Global Rifaximin API Market Size Market Share by Region: 2020 Versus 2026
    Figure 11. Rifaximin API Sales Share by Manufacturers in 2020
    Figure 12. Global Rifaximin API Revenue Share by Manufacturers in 2019
    Figure 13. The Global 5 and 10 Largest Players: Market Share by Rifaximin API Revenue in 2019
    Figure 14. Rifaximin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 15. Global Rifaximin API Sales Market Share by Region (2015-2020)
    Figure 16. Global Rifaximin API Sales Market Share by Region in 2019
    Figure 17. Global Rifaximin API Revenue Market Share by Region (2015-2020)
    Figure 18. Global Rifaximin API Revenue Market Share by Region in 2019
    Figure 19. North America Rifaximin API Sales Market Share by Country in 2019
    Figure 20. North America Rifaximin API Revenue Market Share by Country in 2019
    Figure 21. U.S. Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 22. U.S. Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 23. Canada Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 24. Canada Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 25. Europe Rifaximin API Sales Market Share by Country in 2019
    Figure 26. Europe Rifaximin API Revenue Market Share by Country in 2019
    Figure 27. Germany Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 28. Germany Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 29. France Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 30. France Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 31. U.K. Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 32. U.K. Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 33. Italy Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 34. Italy Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 35. Russia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 36. Russia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 37. Asia Pacific Rifaximin API Sales Market Share by Region in 2019
    Figure 38. Asia Pacific Rifaximin API Revenue Market Share by Region in 2019
    Figure 39. China Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 40. China Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 41. Japan Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 42. Japan Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 43. South Korea Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 44. South Korea Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. India Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 46. India Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. Australia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 48. Australia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 49. Taiwan Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 50. Taiwan Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. Indonesia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 52. Indonesia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. Thailand Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 54. Thailand Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. Malaysia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 56. Malaysia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. Philippines Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 58. Philippines Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Vietnam Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 60. Vietnam Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Latin America Rifaximin API Sales Market Share by Country in 2019
    Figure 62. Latin America Rifaximin API Revenue Market Share by Country in 2019
    Figure 63. Mexico Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 64. Mexico Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. Brazil Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 66. Brazil Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. Argentina Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 68. Argentina Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. Middle East and Africa Rifaximin API Sales Market Share by Country in 2019
    Figure 70. Middle East and Africa Rifaximin API Revenue Market Share by Country in 2019
    Figure 71. Turkey Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 72. Turkey Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Saudi Arabia Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 74. Saudi Arabia Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. U.A.E Rifaximin API Sales Growth Rate (2015-2020) (Kiloton)
    Figure 76. U.A.E Rifaximin API Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Sales Market Share of Rifaximin API by Type (2015-2020)
    Figure 78. Sales Market Share of Rifaximin API by Type in 2019
    Figure 79. Revenue Share of Rifaximin API by Type (2015-2020)
    Figure 80. Revenue Market Share of Rifaximin API by Type in 2019
    Figure 81. Global Rifaximin API Sales Growth by Type (2015-2020) (Kiloton)
    Figure 82. Global Rifaximin API Sales Market Share by Application (2015-2020)
    Figure 83. Global Rifaximin API Sales Market Share by Application in 2019
    Figure 84. Global Revenue Share of Rifaximin API by Application (2015-2020)
    Figure 85. Global Revenue Share of Rifaximin API by Application in 2020
    Figure 86. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 87. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 88. LGM Pharma Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 89. B Joshi Agrochem Pharma Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 90. Triveni Interchem Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 91. Price Trend of Key Raw Materials
    Figure 92. Manufacturing Cost Structure of Rifaximin API
    Figure 93. Manufacturing Process Analysis of Rifaximin API
    Figure 94. Rifaximin API Industrial Chain Analysis
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Porter's Five Forces Analysis
    Figure 98. North America Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 99. North America Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 100. Europe Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 101. Europe Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 102. Latin America Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 103. Latin America Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 104. Middle East and Africa Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 105. Middle East and Africa Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 106. Asia Pacific Rifaximin API Sales (Kiloton) and Growth Rate Forecast (2021-2026)
    Figure 107. Asia Pacific Rifaximin API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and Japan NT 3 Growth Factor Receptor Market Insights Forecast to 2026
Global and Japan NT 3 Growth Factor Receptor Market Insights, Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-10T3620
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

Global and Japan Conjugated Estrogen Market Insights Forecast to 2026
Global and Japan Conjugated Estrogen Market Insights, Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-1S3814
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

Global and United States Nasal Polyposis Drug Market Insights Forecast to 2026
Global and United States Nasal Polyposis Drug Market Insights, Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-13V3673
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

Global Penicillamine Market Research Report 2020
Global Penicillamine Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-9M3628
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0